Mallinckrodt to Acquire Therakos for $1.33 Billion

August 10, 2015 12:07 PM

49 0

LONDON — The drug maker and medical devices company Mallinckrodt Pharmaceuticals said on Monday that it had agreed to buy Therakos from the American private equity firm the Gores Group for about $1.33 billion.

The deal for Therakos, a maker of immunotherapy drugs, is expected to broaden Mallinckrodt’s branded specialty drug segment and to expand its business in hospitals.

Also read: FDA approves BioMarin rare metabolic disorder drug, shares rise

Read more

To category page